Neumora cut to Hold at Stifel after J&J’s VENTURA exit
by Contributor since / Followers
2 weeks ago
Neumora Therapeutics (NASDAQ:NMRA) fell ~11% in the premarket on Friday as Stifel downgraded the biotech after efficacy concerns prompted J&J (NYSE:JNJ) to discontinue a late-stage program called VENTURA designed to assess a drug candidate similar to NMRA’s lead asset.